These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33843656)

  • 1. Treatment modification after second-line failure among people living with HIV in the Asia-Pacific.
    Jiamsakul A; Azwa I; Zhang F; Yunihastuti E; Ditangco R; Kumarasamy N; Ng OT; Chan YJ; Ly PS; Choi JY; Lee MP; Pujari S; Kiertiburanakul S; Chaiwarith R; Merati TP; Sangle S; Khusuwan S; Sim BL; Avihingsanon A; Duy C; Tanuma J; Ross J; Law M; Asia-Pacific TAHODOI
    Antivir Ther; 2020; 25(7):377-387. PubMed ID: 33843656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD).
    Zhou J; Li PC; Kumarasamy N; Boyd M; Chen YM; Sirisanthana T; Sungkanuparph S; Oka S; Tau G; Phanuphak P; Saphonn V; Zhang FJ; Omar SF; Lee CK; Ditangco R; Merati TP; Lim PL; Choi JY; Law MG; Pujari S;
    HIV Med; 2010 Jan; 11(1):31-9. PubMed ID: 19601993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia.
    Jiamsakul A; Sungkanuparph S; Law M; Kantor R; Praparattanapan J; Li PC; Phanuphak P; Merati T; Ratanasuwan W; Lee CK; Ditangco R; Mustafa M; Singtoroj T; Kiertiburanakul S;
    J Int AIDS Soc; 2014; 17(1):19053. PubMed ID: 25141905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
    Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
    Gilks CF; Walker AS; Munderi P; Kityo C; Reid A; Katabira E; Goodall RL; Grosskurth H; Mugyenyi P; Hakim J; Gibb DM;
    PLoS One; 2013; 8(2):e57580. PubMed ID: 23437399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of WHO immunologic criteria for treatment failure: implications for detection of virologic failure, evolution of drug resistance and choice of second-line therapy in India.
    Vallabhaneni S; Chandy S; Heylen E; Ekstrand ML
    J Int AIDS Soc; 2013 Jun; 16(1):18449. PubMed ID: 23735817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
    Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
    J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-Pacific.
    Ross J; Jiamsakul A; Kumarasamy N; Azwa I; Merati TP; Do CD; Lee MP; Ly PS; Yunihastuti E; Nguyen KV; Ditangco R; Ng OT; Choi JY; Oka S; Sohn AH; Law M
    HIV Med; 2021 Mar; 22(3):201-211. PubMed ID: 33151020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
    Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
    BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.
    Khan S; Das M; Andries A; Deshpande A; Mansoor H; Saranchuk P; Isaakidis P
    Glob Health Action; 2014; 7():24861. PubMed ID: 25084835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality after failure of antiretroviral therapy in sub-Saharan Africa.
    Keiser O; Tweya H; Braitstein P; Dabis F; MacPhail P; Boulle A; Nash D; Wood R; Lüthi R; Brinkhof MW; Schechter M; Egger M;
    Trop Med Int Health; 2010 Feb; 15(2):251-8. PubMed ID: 20003034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
    Humphreys EH; Chang LW; Harris J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006517. PubMed ID: 20556768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
    Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
    BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
    Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008270. PubMed ID: 23740608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region.
    Wright S; Boyd MA; Yunihastuti E; Law M; Sirisanthana T; Hoy J; Pujari S; Lee MP; Petoumenos K;
    PLoS One; 2013; 8(6):e64902. PubMed ID: 23840312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa.
    Ncaca LN; Kranzer K; Orrell C
    PLoS One; 2011; 6(8):e23088. PubMed ID: 21858001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
    Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
    J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
    PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.